Prior information notice
This notice is for prior information only
Section I: Contracting
authority
I.1) Name and addresses
NHS England
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
UK
Contact person: Jessica Gaucher-Thompson
E-mail: jessica.gaucher-thompson@nhs.net
NUTS: UKJ1
Internet address(es)
Main address: https://www.england.nhs.uk/
Address of the buyer profile: https://www.england.nhs.uk/
I.3) Communication
Additional information can be obtained from the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
https://health-family.force.com/s/Welcome
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Market Engagement Exercise: Specialised Paediatric whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndrome
II.1.2) Main CPV code
85100000
II.1.3) Type of contract
Services
II.1.4) Short description
NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England Specialised Commissioning (referred to as the Commissioner), is undertaking a market engagement exercise to understand the current and future capacity and capability of potential providers within this specialised area.<br/><br/>This notice is to advise prospective providers in the market of the commissioner’s intention to commission this service and to provide an opportunity to engage with and participate in a market engagement questionnaire.<br/><br/>The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered to inform the commissioning approach.<br/><br/>Participation to this market engagement will close at 12pm (noon), Monday 4th August 2025.
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
NHS England would like to identify providers who are interested in the provision of Specialised Paediatric whole-body MRI (WBMRI) Surveillance for Cancer Predisposing Syndromes.<br/><br/>The key objective of this market engagement process is to obtain relevant feedback and information from the market to understand the level of capability, capacity, competition and will help inform the commissioning strategy in relation to these Services. <br/><br/>Inherited cancer predisposition syndromes are genetic conditions that increase the risk of developing one or more types of cancer. This service will focus on three rare inherited cancer predisposition syndromes; Li-Fraumeni syndrome (LFS), constitutional mismatch repair deficiency syndrome (CMMRD) and rhabdoid tumour predisposition syndrome (RTPS). Published clinical guidelines for these conditions recommend the use of regular whole-body MRI (WBMRI) with the aim of detecting cancers at an early stage.<br/> <br/>The overall aim of MRI surveillance for children with cancer predisposing syndromes is to provide WBMRI screening for patients with LFS, CMMRD and RTPS. The provision of expanded capacity for WBMRI scanning aims to improve clinical care of individuals once an inherited cancer predisposition has been diagnosed. <br/><br/>The anticipated contract duration for this service is 3 years, with the Commissioner having the option to extend the contract up to a further 2 years (maximum contract duration 5 years).<br/><br/>Documentation relating to this exercise including a questionnaire is available through the Atamis (Health Family) portal. To register your interest and access the questionnaire, please follow this link to the Atamis (HealthFamily) portal: https://atamis-1928.my.salesforce-sites.com/?searchtype=Projects<br/><br/>The project reference is C371530 and the closing date for submission of the completed questionnaire is: 12pm (noon) Monday 4th August 2025.
II.3) Estimated date of publication of contract notice:
30/09/2025
Section IV: Procedure
IV.1) Description
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section VI: Complementary information
VI.5) Date of dispatch of this notice
09/07/2025